title: Reduction of mortality in specific-pathogen-free layer chickens by a caprine serum fraction after infection with Pasteurella multocida.
abstract: Caprine serum was fractionated by size, and its proteinaceous material <8,000 Da [caprine serum fraction immunomodulator 2 (CSF-I2)] was evaluated for its ability to impart immunoresistance to specific-pathogen-free (SPF) layer chickens. The SPF layers were challenged with 18 to 30 cfu of Pasteurella multocida X-73 (serotype 1) at 5 wk of age. A high degree of mortality was apparent 24 and 48 h later (62+/-14% and 88+/-7%, respectively). Mortality observed after 48 h was minimal. Noting the rapid onset of mortality, we administered CSF-I2 (material that expressed no direct antimicrobial activity but was believed to be an immunostimulant) 1 d before challenge and coincident to time of challenge. The group of birds that received CSF-I2 (either 5 or 10 mg per administration) expressed significant reduction in mortality throughout the 1-wk study period. Reduction in mortality appeared to be dose dependent. Birds that received two administrations of 10 mg CSF-I2 had significantly fewer deaths than did the group of birds that received half that amount. No deaths were recorded through 24 h, whereas, at 48 h, the percentage mortality was 13 in CSF-I2-treated birds. This study demonstrates that one or more small molecular weight compounds isolated from caprine serum were able to reduce mortality in SPF layers infected with Pasteurella multocida.
authors.affiliation: Department of Biochemistry and Molecular Biology, Mississippi State University, Mississippi State 39762-9665, USA. kowmsu@ra.msstate.edu
authors.forename: K O
authors.initials: KO
authors.lastname: Willeford
authors.forename: T A
authors.initials: TA
authors.lastname: Parker
authors.forename: E D
authors.initials: ED
authors.lastname: Peebles
authors.forename: C
authors.initials: C
authors.lastname: Wang
authors.forename: E W
authors.initials: EW
authors.lastname: Jones
mesh_terms: D000276:Adjuvants, Immunologic / Q000097:blood / Q000627:therapeutic use*; D000818:Animals; D015496:CD4-Positive T-Lymphocytes; D018414:CD8-Positive T-Lymphocytes; D002645:Chickens; D006041:Goats / Q000097:blood*; D007958:Leukocyte Count; D018655:Lymphocyte Count; D010326:Pasteurella Infections / Q000401:mortality / Q000628:therapy / Q000662:veterinary*; D016979:Pasteurella multocida; D011201:Poultry Diseases / Q000276:immunology / Q000401:mortality* / Q000628:therapy; D013047:Specific Pathogen-Free Organisms; D013997:Time Factors
chemical_list: D000276:Adjuvants, Immunologic